Emma Tillman

Research Associate Professor

Indiana University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Emma Tillman is a Research Associate Professor at Indiana University School of Medicine in the United States. Her research primarily focuses on pharmacogenomics, mental health in cystic fibrosis, and pediatric obesity. She has contributed to various studies regarding the implementation of pharmacogenomic practices and the pharmacological effects of treatments in pediatric populations. Recent publications include investigations on the interaction of cannabidiol and tacrolimus, as well as predictors of treatment outcomes in cystic fibrosis patients.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Sara Quinney

Professor

Indiana University School of Medicine

UNITED STATES

View details

Christina Jayne (CJ) Bathgate

Faculty, Assistant Professor - Clinical/Research

National Jewish Health

UNITED STATES

View details

james hicks

University of South Florida

UNITED STATES

View details

Tyler Shugg

Indiana University School of Medicine

UNITED STATES

View details

Christopher Bartlett

Associate Professor

Ohio State University

UNITED STATES

View details

David C. Young

University of Utah Health

UNITED STATES

View details

Katherine Gallaway

Indiana University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emma Tillman

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Elexacaftor/tezacaftor/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation's Prioritizing Research in Mental Health working group

Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis

Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs

A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus

Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis

Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned

A systematic review of dexmedetomidine pharmacology in pediatric patients

Precision medicine to identify, prevent, and treat pediatric obesity

Prevalence of cannabidiol use in persons with cystic fibrosis

Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566

Implementation of Clinical Cytochrome P450 3A Genotyping for Tacrolimus Dosing in a Large Kidney Transplant Program

The Potential Impact of Preemptive Pharmacogenetic Genotyping in the Neonatal Intensive Care Unit

Pharmacogenetic informed care in early childhood: options for improving access and health equity

Acute beta blocker toxicity despite history of medication compliance

The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics

A survey assessing the impact of COVID‐19 and elexacaftor/tezacaftor/ifavacaftor on both physical and mental health in adults with cystic fibrosis

Opportunity for pharmacogenetics testing in patients with sickle cell anemia

A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients

Pharmacogenomics: a tool to improve medication safety and efficacy in patients with cystic fibrosis

Opportunity for pharmacogenomic testing in patients with cystic fibrosis

Collaborators (7)

Sara Quinney

Christina Jayne (CJ) Bathgate

james hicks

Tyler Shugg

Christopher Bartlett

David C. Young

Katherine Gallaway

Make your next move.